The global amniotic membrane market is set to experience substantial growth, with projections estimating the market will surpass US$ 6.59 billion by 2032, up from US$ 2.44 billion in 2023. This growth reflects a CAGR of 11.68% from 2024 to 2032, driven by the increasing demand for minimally invasive (MI) treatments, the rising prevalence of chronic conditions such as rheumatoid arthritis and...